JP2000501949A - 体外搬出法のための患者特異性免疫吸着剤およびその製出法 - Google Patents
体外搬出法のための患者特異性免疫吸着剤およびその製出法Info
- Publication number
- JP2000501949A JP2000501949A JP9515406A JP51540697A JP2000501949A JP 2000501949 A JP2000501949 A JP 2000501949A JP 9515406 A JP9515406 A JP 9515406A JP 51540697 A JP51540697 A JP 51540697A JP 2000501949 A JP2000501949 A JP 2000501949A
- Authority
- JP
- Japan
- Prior art keywords
- patient
- specific
- antibody
- plasma
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3679—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits by absorption
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3472—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration with treatment of the filtrate
- A61M1/3486—Biological, chemical treatment, e.g. chemical precipitation; treatment by absorbents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3202—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the carrier, support or substrate used for impregnation or coating
- B01J20/3206—Organic carriers, supports or substrates
- B01J20/3208—Polymeric carriers, supports or substrates
- B01J20/3212—Polymeric carriers, supports or substrates consisting of a polymer obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
- B01J20/30—Processes for preparing, regenerating, or reactivating
- B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
- B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
- B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
- B01J20/3268—Macromolecular compounds
- B01J20/3272—Polymers obtained by reactions otherwise than involving only carbon to carbon unsaturated bonds
- B01J20/3274—Proteins, nucleic acids, polysaccharides, antibodies or antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/02—Peptides being immobilised on, or in, an organic carrier
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J2220/00—Aspects relating to sorbent materials
- B01J2220/40—Aspects relating to the composition of sorbent or filter aid materials
- B01J2220/48—Sorbents characterised by the starting material used for their preparation
- B01J2220/4812—Sorbents characterised by the starting material used for their preparation the starting material being of organic character
- B01J2220/4856—Proteins, DNA
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/824—Immunological separation techniques
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Anesthesiology (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Biodiversity & Conservation Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Transplantation (AREA)
- External Artificial Organs (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1、患者の病因に関連する免疫因子の免疫複合体から分離した抗原および/また は抗体からなる患者特異の免疫吸着剤であって、活性化した固体担体に結合した もの。 2、請求項1記載の患者特異性の免疫吸着剤であって、免疫系調節不全に起因ま たはこれが持続させる疾患を有する患者の分離した抗原および/または抗体を含 むもの。 3、請求項1および2記載の患者特異性の免疫吸着剤であって、リューマチ様関 節炎、急性進行性糸球体腎炎、全身性紅斑性狼瘡、多発性硬化症、抗燐脂質症候 群、脈管炎、組織不適合移植組織の受容者、多筋炎、神経性自己免疫疾患あるい は感染症の後遺症としての免疫病理学的調節不全などの自己免疫疾患の患者また は免疫病理学的反応状態にある患者の分離した抗原および/または抗体を含むも の。 4、請求項1〜3記載の患者特異性の免疫吸着剤であって、リューマチ様関節炎 、紅斑性狼瘡あるいは多発性硬化症の患者の分離した抗原および(または)抗体 を含むもの。 5、請求項1〜4記載の患者特異性の免疫吸着剤であって、免疫複合体成分をそ の表面に十分に多く共有結合することができる生体親和性物質に結合したもの。 6、セファローゼまたはパールセルロースに結合した患者特異性の免疫吸着剤。 7、請求項1〜6記載の患者特異性の免疫吸着剤の製法であって、患者の血液ま たは他の体液、たとえば髄液から周知の方法、たとえばプロテインA免疫吸着剤 を介するプラズマ搬出法(血漿分離法)で免疫複合体を分離し、これを臨床使用 のため体外浄血法で洗浄し、活性の成分である抗体および抗原に分解し、これら 成分を固体の担体に共有結合させることを特徴とする製法。 8、請求項7の方法で、酸性ないしアルカリ性環境、特に pH 領域2〜5もしく は10〜12にてNoCl、MgCl2、LiCl などの塩または尿素あるいは塩酸グアニジ ンを加え、免疫複合体を個々の成分に分解し、場合によっては分別後、場合によ っては特定濃度以上で反応パートナーを解離状態に保つのに適する NaCl、MgCl2 、LiCl などの塩あるいは尿素、あるいは塩酸グアニシジンを加え、周知の方法 により pH2〜12領域で固体担体にカツプリングさせることを特徴とする請求 項7記載の方法。 9、請求項1〜6記載の患者特異性の免疫吸着剤の体外搬出法への使用。 10、請求項1〜6記載の患者特異性の免疫吸着剤の身体固有の免疫学的に有意 な物質の 製造およびその加工への使用。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19538641.8 | 1995-10-05 | ||
DE19538641A DE19538641C2 (de) | 1995-10-05 | 1995-10-05 | Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung |
PCT/DE1996/001910 WO1997014964A2 (de) | 1995-10-05 | 1996-10-03 | Patientenspezifische immunadsorber für die extrakorporale apherese und verfahren für deren herstellung |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000501949A true JP2000501949A (ja) | 2000-02-22 |
JP3930564B2 JP3930564B2 (ja) | 2007-06-13 |
Family
ID=7775080
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP51540697A Expired - Fee Related JP3930564B2 (ja) | 1995-10-05 | 1996-10-03 | 体外搬出法のための患者特異性免疫吸着剤およびその製出法 |
Country Status (14)
Country | Link |
---|---|
US (1) | US6866846B1 (ja) |
EP (1) | EP0859957B1 (ja) |
JP (1) | JP3930564B2 (ja) |
AT (1) | ATE215697T1 (ja) |
AU (1) | AU727699B2 (ja) |
CA (1) | CA2234088A1 (ja) |
DE (2) | DE19538641C2 (ja) |
DK (1) | DK0859957T3 (ja) |
HU (1) | HU226017B1 (ja) |
NO (1) | NO321159B1 (ja) |
NZ (1) | NZ330102A (ja) |
PL (1) | PL184541B1 (ja) |
RU (1) | RU2167705C2 (ja) |
WO (1) | WO1997014964A2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001802A1 (fr) * | 2006-06-27 | 2008-01-03 | Asahi Kasei Kabushiki Kaisha | Substrat pour traitement de fluide biologique |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19538641C2 (de) * | 1995-10-05 | 2000-09-21 | Privates Inst Bioserv Gmbh | Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung |
US6620382B1 (en) * | 1998-05-22 | 2003-09-16 | Biopheresis Technologies, Llc. | Method and compositions for treatment of cancers |
US8197430B1 (en) * | 1998-05-22 | 2012-06-12 | Biopheresis Technologies, Inc. | Method and system to remove cytokine inhibitor in patients |
AU4860600A (en) * | 1999-06-03 | 2000-12-28 | Advanced Extravascular Systems | One step removal of unwanted molecules from circulating blood |
AU1267501A (en) * | 1999-09-07 | 2001-04-10 | Bioserv Ag | Novel autogenous vaccines used to obtain an immune tolerance |
US8865172B2 (en) | 2000-05-08 | 2014-10-21 | Advanced Extravascular Systems, Inc. | Method for reducing the number of unwanted molecules in bodily fluids |
DE10036742A1 (de) * | 2000-07-27 | 2002-02-21 | Aesku Lab Diagnostika | Vorrichtung zur Behandlung von Immunerkrankungen |
AT410636B (de) * | 2001-03-23 | 2003-06-25 | Igeneon Krebs Immuntherapie | Verfahren zur herstellung eines impfstoffes |
WO2003012396A2 (en) * | 2001-08-01 | 2003-02-13 | Chauhan Anil K | Immune complexes |
JP2008511340A (ja) * | 2004-04-30 | 2008-04-17 | バイオフェレシス テクノロジーズ, インコーポレイテッド | 患者において可溶性tnfr1、可溶性tnfr2、および可溶性il2を除去する方法およびシステム |
DE102004037475A1 (de) * | 2004-07-30 | 2006-03-23 | Heinrich, Hans-Werner, Prof. Dr. | Filtersystem zur membrangetrennten, adsorptiven Behandlung partikelhaltiger Flüssigkeiten |
US20060159680A1 (en) * | 2005-01-14 | 2006-07-20 | Smith Henry J | Targeted apherisis for the treatment of rheumatoid arthritis |
EP2021025B1 (en) * | 2006-05-12 | 2016-08-17 | ITH Immune Therapy Holdings AB | Method and means for treating inflammatory bowel disease |
DE102008025965A1 (de) | 2008-05-30 | 2009-12-03 | Heinrich, Hans-Werner, Prof. Dr. | Verfahren zur Isolierung von Zellen und Krankheitserregern aus Körperflüssigkeiten |
WO2010029317A2 (en) | 2008-09-10 | 2010-03-18 | Ibd Column Therapies International Ab | Treating inflammatory conditions |
US8979787B2 (en) * | 2011-01-20 | 2015-03-17 | Henry John Smith | Treatment of pre-eclampsia using targeted apheresis |
US20130068691A1 (en) * | 2011-08-05 | 2013-03-21 | Henry John Smith | Targeted apheresis for the treatment of rheumatoid arthritis and immune disorders |
NZ700025A (en) * | 2012-02-15 | 2018-07-27 | Biocon Ltd | A process for detection and optional quantification of an analyte |
US9717841B2 (en) | 2012-09-11 | 2017-08-01 | Gary L. McNeil | Closed-circuit device and methods for isolation, modification, and re-administration of specific constituents from a biological fluid source |
EP3477300A1 (de) * | 2017-10-25 | 2019-05-01 | Euroimmun Medizinische Labordiagnostika AG | Zellulose-basierter immunadsorber |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964467A (en) * | 1973-01-30 | 1976-06-22 | Bio Response Inc. | Methods and apparatus for augmentation of the production of anti-bodies in animals and humans and the collection thereof |
US4551433A (en) * | 1981-05-18 | 1985-11-05 | Genentech, Inc. | Microbial hybrid promoters |
US4551435A (en) * | 1983-08-24 | 1985-11-05 | Immunicon, Inc. | Selective removal of immunospecifically recognizable substances from solution |
US4681870A (en) * | 1985-01-11 | 1987-07-21 | Imre Corporation | Protein A-silica immunoadsorbent and process for its production |
WO1986007152A1 (en) * | 1985-05-31 | 1986-12-04 | Biostar Medical Products, Inc. | Method and article for detection of immune complexes |
DE3750544D1 (de) * | 1986-11-21 | 1994-10-20 | Imre Corp | Antigen-spezifisches Entfernen von zirkulierenden Immunokomplexen. |
US5122112A (en) * | 1986-11-21 | 1992-06-16 | Imre Corporation | Antigen-specific removal of circulating immune complexes |
DE19538641C2 (de) * | 1995-10-05 | 2000-09-21 | Privates Inst Bioserv Gmbh | Patientenspezifische Immunadsorber für die extrakorporale Apherese und Verfahren für deren Herstellung |
-
1995
- 1995-10-05 DE DE19538641A patent/DE19538641C2/de not_active Expired - Lifetime
-
1996
- 1996-10-03 EP EP96945812A patent/EP0859957B1/de not_active Expired - Lifetime
- 1996-10-03 WO PCT/DE1996/001910 patent/WO1997014964A2/de active IP Right Grant
- 1996-10-03 HU HU9900462A patent/HU226017B1/hu not_active IP Right Cessation
- 1996-10-03 AU AU17162/97A patent/AU727699B2/en not_active Ceased
- 1996-10-03 AT AT96945812T patent/ATE215697T1/de active
- 1996-10-03 RU RU98108614/14A patent/RU2167705C2/ru not_active IP Right Cessation
- 1996-10-03 PL PL96325897A patent/PL184541B1/pl not_active IP Right Cessation
- 1996-10-03 DK DK96945812T patent/DK0859957T3/da active
- 1996-10-03 CA CA002234088A patent/CA2234088A1/en not_active Abandoned
- 1996-10-03 JP JP51540697A patent/JP3930564B2/ja not_active Expired - Fee Related
-
1997
- 1997-04-04 DE DE19714913A patent/DE19714913B4/de not_active Expired - Fee Related
- 1997-10-03 NZ NZ330102A patent/NZ330102A/en unknown
-
1998
- 1998-04-03 US US09/054,888 patent/US6866846B1/en not_active Expired - Fee Related
- 1998-04-03 NO NO19981530A patent/NO321159B1/no not_active IP Right Cessation
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008001802A1 (fr) * | 2006-06-27 | 2008-01-03 | Asahi Kasei Kabushiki Kaisha | Substrat pour traitement de fluide biologique |
JP5096332B2 (ja) * | 2006-06-27 | 2012-12-12 | 旭化成株式会社 | 生物学的液体処理用基材、生物学的液体処理用基材の製造方法、生物学的液体処理用デバイス、及び生物学的液体処理用デバイスの製造方法 |
Also Published As
Publication number | Publication date |
---|---|
NO981530D0 (no) | 1998-04-03 |
RU2167705C2 (ru) | 2001-05-27 |
ATE215697T1 (de) | 2002-04-15 |
PL184541B1 (pl) | 2002-11-29 |
EP0859957A2 (de) | 1998-08-26 |
US6866846B1 (en) | 2005-03-15 |
NZ330102A (en) | 2001-02-23 |
DK0859957T3 (da) | 2002-07-29 |
PL325897A1 (en) | 1998-08-17 |
JP3930564B2 (ja) | 2007-06-13 |
DE19714913B4 (de) | 2013-04-18 |
EP0859957B1 (de) | 2002-04-03 |
NO981530L (no) | 1998-06-04 |
NO321159B1 (no) | 2006-03-27 |
HUP9900462A2 (hu) | 1999-05-28 |
HU226017B1 (en) | 2008-03-28 |
DE19538641A1 (de) | 1997-04-17 |
WO1997014964A2 (de) | 1997-04-24 |
DE19538641C2 (de) | 2000-09-21 |
AU727699B2 (en) | 2000-12-21 |
AU1716297A (en) | 1997-05-07 |
WO1997014964A3 (de) | 1997-06-12 |
DE19714913A1 (de) | 1998-10-08 |
HUP9900462A3 (en) | 2001-03-28 |
CA2234088A1 (en) | 1997-04-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2000501949A (ja) | 体外搬出法のための患者特異性免疫吸着剤およびその製出法 | |
US4770774A (en) | Column for removing β2 -microglobulin | |
CN101420992B (zh) | 用于体外处理含粒子的液体的可再生过滤器及其应用 | |
US4865841A (en) | Methods and compositions for transient elimination of humoral immune antibodies | |
WO1997014964A9 (de) | Patientenspezifische immunadsorber für die extrakorporale apherese und verfahren für deren herstellung | |
JP2002539910A (ja) | 敗血症療法のための免疫吸着剤 | |
WO2019084111A1 (en) | APPARATUS AND METHODS FOR REMOVING TOXINS FROM BLOOD BY PLASMASPHERESIS | |
Chang | Blood compatible coating of synthetic immunoadsorbents | |
Ostlund Jr | Immunosorbent Chemistry: A Study of Agarose‐Based Column Sorbents for the Removal of Low‐Density Lipoprotein (LDL) from Blood | |
US20120165781A1 (en) | Targeted apheresis for the treatment of rheumatoid arthritis | |
Weber et al. | Specific blood purification by means of antibody-conjugated magnetic microspheres | |
US6309999B1 (en) | Process for the preparation of an immunoadsorbent matrix | |
Denizli et al. | Biologically modified PHEMA beads for hemoperfusion: preliminary studies | |
Yamamoto et al. | Selective Removal of Anti‐Acetylcholine Receptor Antibodies and IgG In Vitro with an Immunoadsorbent Containing Immobilized Sulfathiazole | |
JPS63212370A (ja) | 免疫グロブリン−gおよび循環免疫複合体の体外除去 | |
Ubrich et al. | Selective in vitro removal of anti‐A antibodies by adsorption on encapsulatederythrocyte‐ghosts | |
Singh et al. | Preparation and in vitro evaluation of a new extracorporeal dialyzer with immobilized insulin | |
Marciniak et al. | Quantitative removal of hepatitis B viral antigens from serum by a monoclonal IgM coupled to a biocompatible solid-phase support. | |
JPH0741167B2 (ja) | 生理活性物質固定化吸着剤の製造方法および製造用キット | |
JP3073501B2 (ja) | C―反応性タンパクの修飾形態による免疫複合体の結合 | |
CN117654450A (zh) | 一种血液中脂蛋白的吸附材料及其制备方法和应用 | |
RU2052998C1 (ru) | Способ лечения иммунокомплексных состояний | |
Müller-Schulte et al. | Removal of β2-microglobulin using grafted affinity adsorbents as therapeutic approach for the treatment of hemodialysis patients | |
HU210810A9 (en) | Blood product for parenteral administration | |
CN116618024A (zh) | 一种血液净化吸附剂及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060613 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20060913 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20070213 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20070309 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100316 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110316 Year of fee payment: 4 |
|
LAPS | Cancellation because of no payment of annual fees |